9,167 Shares in Addus HomeCare Corporation $ADUS Purchased by Quantbot Technologies LP

Key Points

• Quantbot Technologies LP has acquired 9,167 shares of Addus HomeCare Corporation valued at approximately $907,000 during the first quarter.
• Analysts are generally positive about Addus HomeCare, with several firms raising their price targets and a consensus rating of "Buy".
• Addus HomeCare recently reported a 21.8% increase in revenue year-over-year, with earnings per share beating consensus estimates by $0.04.

Quantbot Technologies LP acquired a new position in Addus HomeCare Corporation (NASDAQ:ADUS - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 9,167 shares of the company's stock, valued at approximately $907,000.

Several other hedge funds have also bought and sold shares of ADUS. Caitong International Asset Management Co. Ltd boosted its position in Addus HomeCare by 368.3% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 1,255 shares of the company's stock worth $124,000 after purchasing an additional 987 shares in the last quarter. Bailard Inc. purchased a new stake in Addus HomeCare in the 1st quarter worth approximately $208,000. Heritage Family Offices LLP boosted its position in Addus HomeCare by 6.3% in the 1st quarter. Heritage Family Offices LLP now owns 2,417 shares of the company's stock worth $239,000 after purchasing an additional 143 shares in the last quarter. Private Advisor Group LLC boosted its position in Addus HomeCare by 52.4% in the 1st quarter. Private Advisor Group LLC now owns 2,546 shares of the company's stock worth $252,000 after purchasing an additional 875 shares in the last quarter. Finally, Hohimer Wealth Management LLC boosted its position in Addus HomeCare by 6.3% in the 1st quarter. Hohimer Wealth Management LLC now owns 2,561 shares of the company's stock worth $253,000 after purchasing an additional 152 shares in the last quarter. Hedge funds and other institutional investors own 95.35% of the company's stock.

Addus HomeCare Price Performance

NASDAQ ADUS traded down $0.15 during mid-day trading on Friday, hitting $115.17. The stock had a trading volume of 72,791 shares, compared to its average volume of 196,587. The firm's 50 day moving average is $112.06 and its 200 day moving average is $106.96. Addus HomeCare Corporation has a twelve month low of $88.96 and a twelve month high of $136.72. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.74 and a quick ratio of 1.74. The stock has a market capitalization of $2.12 billion, a price-to-earnings ratio of 25.42, a PEG ratio of 1.75 and a beta of 0.80.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last posted its quarterly earnings data on Monday, August 4th. The company reported $1.49 EPS for the quarter, beating the consensus estimate of $1.45 by $0.04. Addus HomeCare had a return on equity of 9.39% and a net margin of 6.51%.The firm had revenue of $349.44 million during the quarter, compared to the consensus estimate of $345.71 million. During the same period in the prior year, the company earned $1.35 EPS. The firm's revenue was up 21.8% compared to the same quarter last year. Equities research analysts forecast that Addus HomeCare Corporation will post 4.59 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several research firms have commented on ADUS. Barclays upped their price objective on Addus HomeCare from $83.00 to $109.00 and gave the stock an "underweight" rating in a research report on Tuesday, August 19th. Macquarie restated an "outperform" rating and issued a $133.00 price objective on shares of Addus HomeCare in a research report on Tuesday, June 10th. Wall Street Zen raised Addus HomeCare from a "hold" rating to a "buy" rating in a research note on Sunday, June 29th. JMP Securities reaffirmed a "market outperform" rating and set a $150.00 target price on shares of Addus HomeCare in a research note on Wednesday, July 16th. Finally, Royal Bank Of Canada upped their target price on Addus HomeCare from $133.00 to $134.00 and gave the stock an "outperform" rating in a research note on Friday, August 22nd. Two investment analysts have rated the stock with a Strong Buy rating, six have assigned a Buy rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of "Buy" and a consensus price target of $138.38.

Insiders Place Their Bets

In related news, Director Veronica Hill-Milbourne sold 1,571 shares of the firm's stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $114.93, for a total transaction of $180,555.03. Following the completion of the sale, the director directly owned 5,067 shares of the company's stock, valued at approximately $582,350.31. This trade represents a 23.67% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Brian Poff sold 7,739 shares of the firm's stock in a transaction dated Monday, August 25th. The stock was sold at an average price of $116.82, for a total value of $904,069.98. Following the sale, the executive vice president directly owned 56,980 shares of the company's stock, valued at $6,656,403.60. The trade was a 11.96% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 34,310 shares of company stock valued at $3,958,375 in the last three months. 4.50% of the stock is currently owned by insiders.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.